BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 9484840)

  • 21. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor.
    Guo D; Dunbar JD; Yang CH; Pfeffer LM; Donner DB
    J Immunol; 1998 Mar; 160(6):2742-50. PubMed ID: 9510175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of insulin, PDGF, interleukin-6, and interferon-gamma on glucose transport in 3T3-L1 cells: lack of cross-talk between tyrosine kinase receptors and JAK/STAT pathways.
    Huppertz C; Schwartz C; Becker W; Horn F; Heinrich PC; Joost HG
    Diabetologia; 1996 Dec; 39(12):1432-9. PubMed ID: 8960823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
    Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells.
    Masamune A; Satoh M; Kikuta K; Suzuki N; Shimosegawa T
    World J Gastroenterol; 2005 Jun; 11(22):3385-91. PubMed ID: 15948243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3.
    Deb A; Zamanian-Daryoush M; Xu Z; Kadereit S; Williams BR
    EMBO J; 2001 May; 20(10):2487-96. PubMed ID: 11350938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase.
    Yu CL; Jove R; Burakoff SJ
    J Immunol; 1997 Dec; 159(11):5206-10. PubMed ID: 9548458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members.
    Ilaria RL; Van Etten RA
    J Biol Chem; 1996 Dec; 271(49):31704-10. PubMed ID: 8940193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDGF stimulates tyrosine phosphorylation of JAK 1 protein tyrosine kinase in human mesangial cells.
    Choudhury GG; Marra F; Kiyomoto H; Abboud HE
    Kidney Int; 1996 Jan; 49(1):19-25. PubMed ID: 8770944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling.
    Chiarugi P; Cirri P; Marra F; Raugei G; Fiaschi T; Camici G; Manao G; Romanelli RG; Ramponi G
    J Biol Chem; 1998 Mar; 273(12):6776-85. PubMed ID: 9506979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer microscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3.
    Biener E; Martin C; Daniel N; Frank SJ; Centonze VE; Herman B; Djiane J; Gertler A
    Endocrinology; 2003 Aug; 144(8):3532-40. PubMed ID: 12865335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions.
    Björnström L; Sjöberg M
    Mol Endocrinol; 2002 Oct; 16(10):2202-14. PubMed ID: 12351686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.
    Demoulin JB; Uyttenhove C; Van Roost E; DeLestré B; Donckers D; Van Snick J; Renauld JC
    Mol Cell Biol; 1996 Sep; 16(9):4710-6. PubMed ID: 8756628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEK is a negative regulator of Stat5b in PDGF-stimulated cells.
    Valgeirsdóttir S; Ruusala A; Heldin CH
    FEBS Lett; 1999 Apr; 450(1-2):1-7. PubMed ID: 10350046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Participation of JAK and STAT proteins in growth hormone-induced signaling.
    Han Y; Leaman DW; Watling D; Rogers NC; Groner B; Kerr IM; Wood WI; Stark GR
    J Biol Chem; 1996 Mar; 271(10):5947-52. PubMed ID: 8621469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells.
    Nosaka T; Kitamura T
    Int J Hematol; 2000 Jun; 71(4):309-19. PubMed ID: 10905049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis.
    Nishio H; Matsui K; Tsuji H; Tamura A; Suzuki K
    J Anat; 2001 May; 198(Pt 5):581-9. PubMed ID: 11430697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kinase-inactive PDGF beta-receptor mediates activation of the MAP kinase cascade via the endogenous PDGF alpha-receptor in HepG2 cells.
    Vaillancourt RR; Gardner AM; Kazlauskas A; Johnson GL
    Oncogene; 1996 Jul; 13(1):151-9. PubMed ID: 8700541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stat6 and Jak1 are common elements in platelet-derived growth factor and interleukin-4 signal transduction pathways in NIH 3T3 fibroblasts.
    Patel BK; Wang LM; Lee CC; Taylor WG; Pierce JH; LaRochelle WJ
    J Biol Chem; 1996 Sep; 271(36):22175-82. PubMed ID: 8703030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.
    Dumoutier L; Tounsi A; Michiels T; Sommereyns C; Kotenko SV; Renauld JC
    J Biol Chem; 2004 Jul; 279(31):32269-74. PubMed ID: 15166220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors.
    Groner B; Fritsche M; Stöcklin E; Berchtold S; Merkle C; Moriggl R; Pfitzner E
    Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S15-20. PubMed ID: 10984248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.